Companies › TSOL

TSOL 10-K & 10-Q changes, risk factors and insider trading

21Shares Solana Staking ETF · CBOE · Commodity Contracts Brokers & Dealers · CIK 2028834 · All filings on SEC.gov

Everything below is quoted or computed from 21Shares Solana Staking ETF's public SEC filings. It is not a recommendation to buy or sell. Automated comparisons can contain errors; confirm with the original filing.

At a glance

0Form 4 filings reporting open-market purchases (last 180 days)
0Form 4 filings reporting open-market sales (last 180 days)

Jump to: Annual report (10-K) · Quarterly report (10-Q) · Insider transactions · 13F holders

What changed in the latest 10-K

Comparison not available: Not available: fewer than two 10-K filings on EDGAR to compare (only one so far)..

What changed in the latest 10-Q

Comparing 10-Q filed 2026-08-12 (period ending 2026-06-30) with 10-Q filed 2026-05-15 (period ending 2026-03-31).

Risk Factors (10-Q Part II, Item 1A)

1new paragraphs
9removed paragraphs
0reworded paragraphs
1,652 → 61words in section

The section in the latest 10-Q reads in full:

There have been no material changes to the Risk Factors last reported under “Part I, Item 1A. Risk Factors” of the Trust’s Annual Report on Form 10-K for the period ended December 31, 2025 and under “Part II, Item 1A. Risk Factors” of the Trust’s Quarterly Report on Form 10-Q for the period ended March 31, 2026.

Removed heading “The Trust Agreement includes a provision restricting Shareholders’ right to bring a derivative action.”

Largest changes (selected automatically by length and topic keywords; quoted verbatim, no commentary)

Removed text topics: lawsuit, fine
“Under Section 7.4 of the Trust Agreement, Shareholders’ statutory right under Delaware law to bring a derivative action (i.e., to initiate a lawsuit in the name of the Trust in order to assert a claim belonging to the Trust against a fiduciary of the Trust or against a third-party when the Trust’s management has refused to do so) is restricted. …”
see in full comparison
Removed text
“The Trust Agreement includes a provision restricting Shareholders’ right to bring a derivative action.”
see in full comparison
Removed text topics: regulation
“These provisions apply to any derivative actions brought in the name of the Trust other than derivative claims brought under the federal U.S. securities laws and the rules and regulations thereunder. The enforceability of Section 7.04’s derivative action threshold and procedural requirements under applicable federal or state law has not been definitively established. …”
see in full comparison
Removed text
“In addition to the 10% ownership threshold described above, the Trust Agreement imposes the following further procedural conditions on any Shareholder seeking to bring a derivative action on behalf of the Trust: …”
see in full comparison
Removed text
“A Shareholder wishing to bring a derivative action on behalf of the Trust must satisfy both the 10% ownership threshold and the pre-suit demand process described above before commencing any such action, suit or other proceeding, further limiting the ability of a Shareholder to seek redress in the name of the Trust. …”
see in full comparison
Removed text
“Moreover, if Shareholders bringing a derivative action, suit or proceeding pursuant to this provision of the Trust Agreement do not hold 10% of the outstanding Shares on the date such an action, suit or proceeding is brought, or such Shareholders are unable to maintain Share ownership meeting the 10% threshold throughout the duration of the action, suit or proceeding, such Shareholders’ derivative action may be subject to dismissal. …”
see in full comparison
Full comparison: every changed paragraph (10)

Green = added, red = removed. Unchanged paragraphs and tables are not shown. Read the complete text in the original filing.

Added

There have been no material changes to the Risk Factors last reported under “Part I, Item 1A. Risk Factors” of the Trust’s Annual Report on Form 10-K for the period ended December 31, 2025 and under “Part II, Item 1A. Risk Factors” of the Trust’s Quarterly Report on Form 10-Q for the period ended March 31, 2026.

Removed

You should carefully consider the risk factors discussed below as well as the risk factors discussed in Part I, Item 1A. “Risk Factors” in our Annual Report, which could materially affect our business, financial condition or future results. Other than as described herein, there have been no material changes in our risk factors from those disclosed in our 2025 Annual Report on Form 10-K.

Removed

The risks described below and in our Annual Report are not the only risks facing the Trust. You should also consider any risks and uncertainties described under the caption “Risk Factors” in any applicable prospectus, prospectus supplement, registration statement or other document that we file with the SEC before or after the date of this prospectus that is incorporated by reference herein. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

Removed

The Trust Agreement includes a provision restricting Shareholders’ right to bring a derivative action.

Removed

Under Section 7.4 of the Trust Agreement, Shareholders’ statutory right under Delaware law to bring a derivative action (i.e., to initiate a lawsuit in the name of the Trust in order to assert a claim belonging to the Trust against a fiduciary of the Trust or against a third-party when the Trust’s management has refused to do so) is restricted. Under Delaware law, a shareholder may bring a derivative action if the shareholder is a shareholder at the time the action is brought and either (i) was a shareholder at the time of the transaction at issue or (ii) acquired the status of shareholder by operation of law or the Trust’s governing instrument from a person who was a shareholder at the time of the transaction at issue. Additionally, Section 3816(e) of the Delaware Statutory Trust Act specifically provides that a “beneficial owner’s right to bring a derivative action may be subject to such additional standards and restrictions, if any, as are set forth in the governing instrument of the statutory trust, including, without limitation, the requirement that beneficial owners owning a specified beneficial interest in the statutory trust join in the bringing of the derivative action.” In addition to the requirements of applicable law and in accordance with Section 3816(e) of the Delaware Statutory Trust Act, the Trust Agreement provides that no Shareholder will have the right, power or authority to bring or maintain a derivative action, suit or other proceeding on behalf of the Trust unless two or more Shareholders who are eligible to bring such derivative action under the Delaware Trust Statute and who (i) are not “Affiliates” (as defined in the Trust Agreement and below) of one another and (ii) collectively hold at least 10% of the outstanding Shares join in the bringing or maintaining of such action, suit or other proceeding. “Affiliate” means (i) any Person directly or indirectly owning, controlling or holding with power to vote 10% or more of the outstanding voting securities of such Person, (ii) any Person 10% or more of whose outstanding voting securities are directly or indirectly owned, controlled or held with power to vote by such Person, (iii) any Person, directly or indirectly, controlling, controlled by or under common control of such Person, (iv) any employee, officer, director, member, manager or partner of such Person, or (v) if such Person is an employee, officer, director, member, manager or partner, any Person for which such Person acts in any such capacity; and “Person” means any natural person and any partnership, limited liability company, statutory trust, corporation, association, or other legal entity.

Removed

In addition to the 10% ownership threshold described above, the Trust Agreement imposes the following further procedural conditions on any Shareholder seeking to bring a derivative action on behalf of the Trust: (1) prior to bringing any such action, two or more non-affiliated Shareholders collectively holding at least 10% of the outstanding Shares must first make a pre-suit demand upon the Sponsor to bring the subject action, unless an effort to cause the Sponsor to bring such an action is not likely to succeed (a demand shall only be deemed not likely to succeed, and therefore excused, if the Sponsor has a personal financial interest in the transaction at issue, and the Sponsor shall not be deemed interested in a transaction or otherwise disqualified from ruling on the merits of a Shareholder demand by virtue of the fact that the Sponsor receives remuneration for his or her service as Sponsor of the Trust or as a trustee or director of one or more trusts that are under common management with or otherwise affiliated with the Trust); and (2) unless a demand is excused pursuant to clause (1) of this paragraph, the Sponsor must be afforded a reasonable amount of time to consider such Shareholder request and to investigate the basis of such claim and the Sponsor shall be entitled to retain counsel or other advisors in considering the merits of the request, and the Sponsor shall require an undertaking by the Shareholders making such request to reimburse the Trust for the expense of any such advisor in the event the Sponsor determines not to take action. Any decision by the Sponsor to bring, maintain, or compromise (or not to bring, maintain, or compromise) any such court action, proceeding or claim, or to submit the matter to a vote of Shareholders, shall be made by the Sponsor in good faith and shall be binding upon the Shareholders. In addition to claims that must be brought derivatively under applicable law, the Trust Agreement requires that any claim affecting all Shareholders of the Trust proportionately, based on their number of Shares of the Trust, must also be brought as a derivative claim subject to these conditions, regardless of whether such claim involves a violation of a Shareholder’s rights under the Trust Agreement or any other alleged violation of contractual or individual rights that might otherwise give rise to a direct claim (and regardless, in each case, of whether such claims sound in tort, fraud or otherwise, or are based on common law, statutory, equitable, legal or other grounds).

Removed

These provisions apply to any derivative actions brought in the name of the Trust other than derivative claims brought under the federal U.S. securities laws and the rules and regulations thereunder. The enforceability of Section 7.04’s derivative action threshold and procedural requirements under applicable federal or state law has not been definitively established. The 10% ownership threshold and procedural requirements represent contractual restrictions on derivative actions authorized by Section 3816(e) of the Delaware Statutory Trust Act, which expressly permits trust instruments to modify or restrict the rights of beneficial owners to bring derivative actions. However, the application of such a threshold in the context of a registered exchange-traded product has not been comprehensively addressed by the courts. Accordingly, it is possible that a court could decline to enforce the Trust’s 10% threshold and procedural requirements.

Removed

A Shareholder wishing to bring a derivative action on behalf of the Trust must satisfy both the 10% ownership threshold and the pre-suit demand process described above before commencing any such action, suit or other proceeding, further limiting the ability of a Shareholder to seek redress in the name of the Trust. Due to these additional requirements, a Shareholder attempting to bring or maintain a derivative action in the name of the Trust will be required to locate other Shareholders with which it is not affiliated and that have sufficient Shares to meet the 10% threshold based on the number of Shares outstanding on the date the claim is brought and thereafter throughout the duration of the action, suit or proceeding. Shareholders wishing to satisfy this ownership threshold would need to identify and coordinate with other Shareholders of the Trust. Because the Trust’s Shares are held in book-entry form through the DTC and beneficial ownership information is not publicly available, individual investors may face substantial difficulty in locating other Shareholders. There is no mechanism established by the Trust to facilitate such shareholder coordination, and the Trust is not required to assist Shareholders in identifying one another. Accordingly, even Shareholders who believe they have a legitimate derivative claim may, as a practical matter, be unable to satisfy the 10% threshold and bring an action. Even if successful, this may be difficult and may result in increased costs to a Shareholder attempting to seek redress in the name of the Trust in court.

Removed

Moreover, if Shareholders bringing a derivative action, suit or proceeding pursuant to this provision of the Trust Agreement do not hold 10% of the outstanding Shares on the date such an action, suit or proceeding is brought, or such Shareholders are unable to maintain Share ownership meeting the 10% threshold throughout the duration of the action, suit or proceeding, such Shareholders’ derivative action may be subject to dismissal. As a result, the Trust Agreement limits the likelihood that a Shareholder will be able to successfully assert a derivative action in the name of the Trust, even if such Shareholder believes that he or she has a valid derivative action, suit or other proceeding to bring on behalf of the Trust.

Removed

Because the Trust’s Shares are held in book-entry form through DTC, the beneficial owners of Shares are generally not reflected on the Trust’s share register. Accordingly, any shareholder or group of Shareholders seeking to establish that they collectively hold at least 10% of the outstanding Shares must provide documentary evidence of their beneficial ownership as of the date of the derivative demand. Acceptable evidence may include broker statements, DTC participant confirmations, account statements from a registered broker-dealer or bank that is a DTC participant, or such other documentation as the Trust may reasonably require.

Management's Discussion & Analysis (MD&A) (10-Q Part I, Item 2)

3new paragraphs
0removed paragraphs
8reworded paragraphs
2,649 → 3,172words in section

Largest changes (selected automatically by length and topic keywords; quoted verbatim, no commentary)

New text
“Net decrease in net assets resulting from operations for the six months ended June 30, 2026 was $(1,600,591), resulting from a net change in unrealized depreciation on investment in solana of $(1,300,734), a net realized loss of $(232,315) from solana sold for redemptions, a net realized loss of $(97,043) from solana sold for distributions, a net realized loss of $(5,401) from solana sold to pay the Sponsor Fee, and a net realized loss of $(2,370) on in-kind liabilities paid, partially offset by a net investment income of $33,783 and a net change in unrealized appreciation on Sponsor Fee …”
see in full comparison
Reworded

Paragraph as it now reads, with added and removed wording marked:

The Trust’s investment objective is to seek to track the performance of solana, as measured by the performance of the Pricing Benchmark, adjusted for the Trust’s expenses and other liabilities, and to reflect rewards from staking a portion of the Trust’s solana, to the extent the Sponsor in its sole discretion determines that the Trust may do so without undue legal or regulatory risk, such as, without limitation, the risk of jeopardizing the Trust’s ability to qualify as a grantor trust for U.S. Federal income tax purposes. CF Benchmarks Ltd. is the Pricing Benchmark Provider. The Pricing Benchmark is designed to reflect the performance of solana in U.S. dollars. In seeking to achieve its investment objective, the Trust holds solana at its Custodians and values its Shares daily based on the Pricing Benchmark. The Trust is a passive investment vehicle and is not a leveraged product. The Sponsor does not actively manage the solana held by the Trust. On June 30, 2026, the Sponsor provided notice to the Pricing Benchmark Provider of the termination, effective August 31, 2026, of the licensing agreement between the Sponsor and the Pricing Benchmark Provider relating to the use of the Pricing Benchmark. The Sponsor intends to enter into a licensing agreement with FTSE on or about August 24, 2026, whereby FTSE will provide each of the Sponsor, the Trust, and their affiliates a non-exclusive, non-transferable, non-sub-licensable, worldwide license to access, view and use FTSE index data to develop, create, calculate, settle, maintain or support and market the Trust. Accordingly, the change in pricing benchmark provider is not expected to have a material impact on the Trust's net asset value, the fair value measurement of the Trust's solana, or the Trust's results of operations, and does not represent a change in accounting principle. The change will be applied prospectively from the date the successor benchmark becomes effective.
see in full comparison
Reworded

Paragraph as it now reads, with added and removed wording marked:

The Trust’s NAV decreased from $5,735,019 on December 31, 2025 to $2,876,514 on March 31, 2026 to $2,847,364 on June 30, 2026, a 33.30%1.01% decrease. The decrease in the Trust’s NAV resulted primarily from a decrease10.95% decline in the price of solana, which decreased 33.32%fell from $123.97 on December 31, 2025 to $82.66 on March 31, 2026.2026 Theto decrease$73.61 wason furtherJune amplified30, 2026, partially offset by a net decreaseincrease in outstanding Shares from 460,000 on December 31, 2025 to 360,000 on March 31, 2026 to 400,000 on June 30, 2026, as a result of 40,000 Shares (4 Baskets) being created and 140,0000 Shares (140 Baskets) being redeemed during the quarter. During the quarter, theThe Trust stakedhad an90.80% average of 42.03% of its solana holdings, though 0.00% washoldings staked as of MarchJune 31,30, 2026.2026, with an average of 43.15% staked on a daily basis during the quarter.
see in full comparison
New text
“The Trust’s NAV decreased from $5,735,019 on December 31, 2025 to $2,847,364 on June 30, 2026, a 50.35% decrease. The decrease resulted primarily from a 40.62% decline in the price of solana, which fell from $123.97 on December 31, 2025 to $73.61 on June 30, 2026. The decrease was amplified by a net decrease in outstanding Shares from 460,000 on December 31, 2025 to 400,000 on June 30, 2026, as a result of 80,000 Shares (8 Baskets) being created and 140,000 Shares (14 Baskets) being redeemed during the period. …”
see in full comparison
Reworded

Paragraph as it now reads, with added and removed wording marked:

Net decrease in net assets resulting from operations for the three months ended MarchJune 31,30, 2026 was $(1,306,978293,613), resulting from a net change in unrealized depreciation on investment in solana of $(1,004,228296,506), a net realized loss of $(232,315)$0 from solana sold for redemptions, a net realized loss of $(86,47110,572) from solana sold for incomedistributions, distribution, a net realized loss of $(3,8011,599) from solana sold to pay the Sponsor Fee, and a net realized loss of $(1,943420) on in-kind liabilities paid, partially offset by a net investment income of $18,991$14,792 and a net change in unrealized appreciation on Sponsor Fee payable of $2,789.$692. Net investment income comprised Staking Rewards of $23,355$18,105 less the Sponsor Fee of $2,028$1,503 and the Staking Fee of $2,336. $1,810. In addition to net assets resulting from operations, the Trust paid atotal staking income distributiondistributions of $120,180$14,379 ($0.035949 per Share on June 29, 2026) to Shareholders during the quarter. OtherExcept thanfor the Sponsor Fee and Staking Fee, the Trust had no other expenses during the quarter.
see in full comparison
Reworded

Paragraph as it now reads, with added and removed wording marked:

The Sponsor is not required to pay any extraordinary or non-routine expenses. Extraordinary expenses are fees and expenses which are unexpected or unusual in nature, such as legal claims and liabilities and litigation costs or indemnification or other unanticipated expenses. Extraordinary fees and expenses also include material expenses which are not currently anticipated obligations of the Trust. The Trust will be responsible for the payment of such expenses to the extent any such expenses are incurred. Routine operational, administrative, and other ordinary expenses are not deemed extraordinary expenses. The Trust will sell solana on an as-needed basis to pay the Sponsor Fee. On July 27, 2026, the Sponsor agreed to voluntarily waive the Sponsor Fee for a period of one year beginning on July 28, 2026 and ending on July 27, 2027.
see in full comparison
Full comparison: every changed paragraph (11)

Green = added, red = removed. Unchanged paragraphs and tables are not shown. Read the complete text in the original filing.

Reworded

The Trust’s investment objective is to seek to track the performance of solana, as measured by the performance of the Pricing Benchmark, adjusted for the Trust’s expenses and other liabilities, and to reflect rewards from staking a portion of the Trust’s solana, to the extent the Sponsor in its sole discretion determines that the Trust may do so without undue legal or regulatory risk, such as, without limitation, the risk of jeopardizing the Trust’s ability to qualify as a grantor trust for U.S. Federal income tax purposes. CF Benchmarks Ltd. is the Pricing Benchmark Provider. The Pricing Benchmark is designed to reflect the performance of solana in U.S. dollars. In seeking to achieve its investment objective, the Trust holds solana at its Custodians and values its Shares daily based on the Pricing Benchmark. The Trust is a passive investment vehicle and is not a leveraged product. The Sponsor does not actively manage the solana held by the Trust. On June 30, 2026, the Sponsor provided notice to the Pricing Benchmark Provider of the termination, effective August 31, 2026, of the licensing agreement between the Sponsor and the Pricing Benchmark Provider relating to the use of the Pricing Benchmark. The Sponsor intends to enter into a licensing agreement with FTSE on or about August 24, 2026, whereby FTSE will provide each of the Sponsor, the Trust, and their affiliates a non-exclusive, non-transferable, non-sub-licensable, worldwide license to access, view and use FTSE index data to develop, create, calculate, settle, maintain or support and market the Trust. Accordingly, the change in pricing benchmark provider is not expected to have a material impact on the Trust's net asset value, the fair value measurement of the Trust's solana, or the Trust's results of operations, and does not represent a change in accounting principle. The change will be applied prospectively from the date the successor benchmark becomes effective.

Reworded

The Trust issues Shares only in Creation Baskets of 10,000 or multiples thereof. Creation Baskets are issued and redeemed in exchange for cash.cash or in-kind for solana. Individual Shares will not be redeemed by the Trust but are listed and traded on the Exchange under the ticker symbol “TSOL”. The Trust issues Shares in Creation Baskets on a continuous basis at the applicable NAV per Share on the creation order date.

Reworded

The NAV of the Trust is used by the Trust in its day-to-day operations to measure the net value of the Trust’s assets. The NAV is calculated on each day otherBusiness than a day when the Exchange is closed for regular trading (a “Business Day”) and is equal to the aggregate value of the Trust’s assets less its liabilities based on the Pricing Benchmark price. In determining the NAV of the Trust on any Business Day, the Administrator calculates the price of the solana held by the Trust as of 4:00 p.m. ET on such day. The Administrator also calculates the “NAV per Share” of the Trust, which equals the NAV of the Trust divided by the number of outstanding Shares.

Reworded

The rewards owed or paid to the Staking Services Provider reducesreduce the amount of solana rewards that are generated from the Trust’s Staking Activities that are available in the assets of the Trust. Each Staking Services Provider that generates staking rewards is entitled to compensation determined as a portion of the staking rewards, which is generally determined by a low single-digit percentage of the overall rewards amount (the “Staking Provider Consideration”). The Staking Provider Consideration is paid directly to the Staking Services Provider from the staking rewards or indirectly through the Custodians’ own accounts. The Trust pays 10% of the staking rewards generated by the Trust’s Staking Activities after deduction of the Staking Provider Consideration to the Sponsor, and retains the remainder.

Reworded

For the Three Months Ended MarchJune 31,30, 2026*

Reworded

The Trust’s NAV decreased from $5,735,019 on December 31, 2025 to $2,876,514 on March 31, 2026 to $2,847,364 on June 30, 2026, a 33.30%1.01% decrease. The decrease in the Trust’s NAV resulted primarily from a decrease10.95% decline in the price of solana, which decreased 33.32%fell from $123.97 on December 31, 2025 to $82.66 on March 31, 2026.2026 Theto decrease$73.61 wason furtherJune amplified30, 2026, partially offset by a net decreaseincrease in outstanding Shares from 460,000 on December 31, 2025 to 360,000 on March 31, 2026 to 400,000 on June 30, 2026, as a result of 40,000 Shares (4 Baskets) being created and 140,0000 Shares (140 Baskets) being redeemed during the quarter. During the quarter, theThe Trust stakedhad an90.80% average of 42.03% of its solana holdings, though 0.00% washoldings staked as of MarchJune 31,30, 2026.2026, with an average of 43.15% staked on a daily basis during the quarter.

Reworded

Net decrease in net assets resulting from operations for the three months ended MarchJune 31,30, 2026 was $(1,306,978293,613), resulting from a net change in unrealized depreciation on investment in solana of $(1,004,228296,506), a net realized loss of $(232,315)$0 from solana sold for redemptions, a net realized loss of $(86,47110,572) from solana sold for incomedistributions, distribution, a net realized loss of $(3,8011,599) from solana sold to pay the Sponsor Fee, and a net realized loss of $(1,943420) on in-kind liabilities paid, partially offset by a net investment income of $18,991$14,792 and a net change in unrealized appreciation on Sponsor Fee payable of $2,789.$692. Net investment income comprised Staking Rewards of $23,355$18,105 less the Sponsor Fee of $2,028$1,503 and the Staking Fee of $2,336. $1,810. In addition to net assets resulting from operations, the Trust paid atotal staking income distributiondistributions of $120,180$14,379 ($0.035949 per Share on June 29, 2026) to Shareholders during the quarter. OtherExcept thanfor the Sponsor Fee and Staking Fee, the Trust had no other expenses during the quarter.

Added

For the Six Months Ended June 30, 2026*

Added

The Trust’s NAV decreased from $5,735,019 on December 31, 2025 to $2,847,364 on June 30, 2026, a 50.35% decrease. The decrease resulted primarily from a 40.62% decline in the price of solana, which fell from $123.97 on December 31, 2025 to $73.61 on June 30, 2026. The decrease was amplified by a net decrease in outstanding Shares from 460,000 on December 31, 2025 to 400,000 on June 30, 2026, as a result of 80,000 Shares (8 Baskets) being created and 140,000 Shares (14 Baskets) being redeemed during the period. The Trust had 90.80% of its solana holdings staked as of June 30, 2026, with an average of 41.96% staked on a daily basis during the period.

Added

Net decrease in net assets resulting from operations for the six months ended June 30, 2026 was $(1,600,591), resulting from a net change in unrealized depreciation on investment in solana of $(1,300,734), a net realized loss of $(232,315) from solana sold for redemptions, a net realized loss of $(97,043) from solana sold for distributions, a net realized loss of $(5,401) from solana sold to pay the Sponsor Fee, and a net realized loss of $(2,370) on in-kind liabilities paid, partially offset by a net investment income of $33,783 and a net change in unrealized appreciation on Sponsor Fee payable of $3,489. Net investment income comprised Staking Rewards of $41,460 less the Sponsor Fee of $3,531 and the Staking Fee of $4,146. In addition to net assets resulting from operations, the Trust paid total staking income distributions of $134,559 ($0.316871 per Share on February 13, 2026, $0.016962 per Share on March 30, 2026, and $0.035949 per Share on June 29, 2026) to Shareholders during the period. Except for the Sponsor Fee and Staking Fee, the Trust had no other expenses during the period.

Reworded

The Sponsor is not required to pay any extraordinary or non-routine expenses. Extraordinary expenses are fees and expenses which are unexpected or unusual in nature, such as legal claims and liabilities and litigation costs or indemnification or other unanticipated expenses. Extraordinary fees and expenses also include material expenses which are not currently anticipated obligations of the Trust. The Trust will be responsible for the payment of such expenses to the extent any such expenses are incurred. Routine operational, administrative, and other ordinary expenses are not deemed extraordinary expenses. The Trust will sell solana on an as-needed basis to pay the Sponsor Fee. On July 27, 2026, the Sponsor agreed to voluntarily waive the Sponsor Fee for a period of one year beginning on July 28, 2026 and ending on July 27, 2027.

TSOL insider buying and selling (Form 4)

Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.

No Form 4 stock transactions in this period.

Well-known investors holding TSOL (13F)

None of the 59 investors we track reported a position in their latest 13F.

Coming soon: email alerts when TSOL files, watchlists and downloadable comparisons.